Irven

Irbesartan, the active ingredient in Irven, is an angiotensin II receptor blocker (ARB) presented as an oral dosage form for oral use. It is prescribed to lower elevated blood pressure, to protect kidney function in patients with type 2 diabetes, and to aid management of chronic heart failure.

GNH USA supplies Irven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution with full regulatory documentation and traceability.

Irbesartan is employed in conditions that involve the renin‑angiotensin system and cardiovascular health.

Hypertension: reduces systolic and diastolic blood pressure, decreasing the risk of stroke and myocardial infarction. Diabetic nephropathy: slows progression of renal disease in patients with type 2 diabetes by lowering intraglomerular pressure. Heart failure: improves symptoms and lowers hospitalization rates in patients with reduced ejection fraction. Proteinuria: decreases urinary protein excretion, contributing to renal protection in chronic kidney disease.

Irbesartan may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion

Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue) - Severe hyperkalemia - Acute kidney injury - Hepatic dysfunction

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor relevant parameters. - Blood pressure monitoring: check regularly to avoid hypotension. - Renal function: assess serum creatinine and eGFR before and during treatment. - Electrolyte balance: monitor potassium levels, especially in renal impairment or when combined with potassium‑sparing agents. - Pregnancy: avoid use during the second and third trimesters due to fetal toxicity risk. - Concomitant ARBs/ACE inhibitors: do not combine to prevent additive renal effects. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Irbesartan can interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid): - ACE inhibitors: concurrent use may cause excessive potassium rise and renal dysfunction. - Potassium‑sparing diuretics or supplements: increase risk of hyperkalemia. - Aliskiren in diabetic patients: heightened risk of renal impairment.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive effect and impair renal function. - Lithium: may increase lithium levels; monitor for toxicity. - Cyclosporine or tacrolimus: may raise serum irbesartan concentrations.